Shanghai hyamab biotechnology

Author: hbxr

August undefined, 2024

Webb19 juli 2024 · 统一社会信用代码：91310115MA1K45BM2G. 执行事务合伙人：戴朝辉关联3家企业. 出资额：1.002万元人民币. 成立日期： 2024-07-19. 电话： 021-58328816 同电话企业 14. 邮箱： [email protected] 更多 1. 官网：. 地址：中国（上海）自由贸易试验区创新西路778号附近企业. ：. WebbAssignee: SHANGHAI HYAMAB BIOTECH CO ., LTD . IPC: C07K16/28. Abstract: Provided are an antibody targeting NKG2A, a preparation method therefor and use thereof. Specifically, provided is a new mouse or humanized monoclonal antibody targeting NKG2A, and a method for preparing the monoclonal antibody. The monoclonal antibody can bind …

上海怀茂企业管理中心（有限合伙） - 企查查

WebbHyaMab的的两个重点研发领域是:1)抗体调控剂2)工程化免疫细胞，增强和维持循环NK细胞的自然杀伤活性。在专有技术平台的支持下，公司继续在免疫肿瘤学(IO)领域建立核心 … how to set primary key in xampp

Shaoping HU Inventions, Patents and Patent Applications - Justia ...

Webb6 apr. 2024 · Shanghai HyaMab Biotech Co.,Ltd. ClinicalTrials.gov Identifier: NCT05801237 Other Study ID Numbers: PE0116-Ib/II : First Posted: April 6, 2024 Key Record Dates: Last … Webb10 maj 2024 · Assignee: Shanghai Hyamab Biotech Co., Ltd. Inventors: Heng Pan, Haohan Liu, Yingying Gao, Shaoping Hu, Yong Li, Mingming Pan, Tatchi Teddy Yang, Qing Duan, Lile Liu Macrocyclic compounds as TRK kinases inhibitors Patent number: 11555042 Abstract: Provided are certain TRK inhibitors, pharmaceutical compositions thereof, and methods … Webb29 sep. 2024 · This work was supported by Shanghai ChemPartner Co., Ltd and Shanghai Hyamab Biotechnology Co., Ltd, and a grant from the National Natural Science … how to set primary key in spring boot

Heng Pan Inventions, Patents and Patent Applications - Justia

patentsgazette.uspto.gov

Webb24 mars 2024 · Shanghai HyaMab Biotech Co.,Ltd. Study record dates These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the … WebbSponsors: Lead Sponsor: Shanghai HyaMab Biotech Co.,Ltd. Source: Shanghai HyaMab Biotech Co.,Ltd. Brief Summary: This is a Phase I Clinical Trial to Evaluate the Tolerability, Safety, Pharmacokinetics and Preliminary Antitumor Activity of PE0116 Injection in Treatment of Patients with Advanced Solid Tumor. how to set primary pdf readerWebbHere, a novel anti‐human CD47 antibody, 4D10, was generated, and its variable regions were grafted onto a human IgG4 scaffold. Compared with the anti‐CD47 antibody Hu5F9, … how to set primary key in sql server

"http://www.exosomes-advanced-therapies-summit.com/ " - Shanghai hyamab biotechnology

Shanghai hyamab biotechnology

ClinicalTrials.gov: "solid tumors" Recruiting, Not yet recruiting ...

WebbBiotechnology Company. Specializing in the Discovery, Development, Production. and Commercialization. Innovative Oncology. Drugs. Academician1 Scientists193 Doctorate Degree29 ... Shanghai Haihe Pharmaceutical Research and Development Co Ltd acquired the stakes of Shanghai RMX Biopharma Co Ltd. December 2024. Webb4 jan. 2024 · Shanghai HyaMab Biotech Co.,Ltd. (1) Collaborator. Intervention. hy-0102 (1) Study Documents. Intervention Type. drug (1) Funder Type. Industry (1) Study Type. …

Did you know?

Webb22 mars 2024 · First Received: March 22, 2024 Last Updated: April 5, 2024. Phase: Phase 1 Start Date: March 8, 2024. Overall Status: Active, not recruiting Estimated ... WebbCondition: Locally Advanced/Metastatic Solid Tumors Intervention: Drug: PE0116&PE0105 Sponsor: Shanghai HyaMab Biotech Co.,Ltd. Not yet recruiting. PE0116 and PE0105 Injection in ... Drug: IMM2902 Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc. Recruiting. IMM2902 in Patients With Advanced Solid Tumors Expressing HER2. ...

WebbShanghai HyaMab Biotech (HyaMab Biotech) is a biotech company focusing on treatment of cancers and autoimmune diseases. HyaMab Biotech is headquartered in Shanghai, … Webb5 nov. 2024 · Provided in the present invention are a 4-1BB antibody and a preparation method and the use thereof. In particular, provided in the present invention are a 4-1BB …

Webb5 apr. 2024 · Shanghai HyaMab Biotech Co.,Ltd. ClinicalTrials.gov Identifier: NCT05800249 Other Study ID Numbers: PE0116-I : First Posted: April 5, 2024 Key Record Dates: Last … Webb5 nov. 2024 · SHANGHAI HYAMAB BIOTECH CO., LTD. (Shanghai, CN) International Classes: C07K16/28; A61P35/00 View Patent Images: Download PDF 20240347144 Primary Examiner: KAUFMAN, CLAIRE M Attorney, Agent or Firm: POLSINELLI PC (Kansas City, MO, US) Claims: 1.

WebbDrugs by Company. Number of drugs Jiangsu Hengrui Medicine 56 CSPC Pharmaceutical 48 Shanghai Fosun Pharmaceutical 46 Sino Biopharmaceutical 42 BeiGene 36 3SBio 34 Shanghai Junshi Biosciences 28 Sihuan Pharmaceutical 27 HEC Pharm 26 Yake Biotechnology 26 Chongqing Zhifei Biological 25 Innovent Biologics 25 Simcere …

WebbAnhui Anke Biotechnology (Group) Co Ltd, Hefei Hankemab Biotechnology Co Ltd: Neoplasms: Details: FTL-001: FTL001; FTL-001: Phase 1 Clinical: Xikang (Wuhan) … how to set primary pdf openerWebbWe have 3 manufacturing facilities, namely Xuhui Facility, Songjiang First Plant and Songjiang Second Plant. Our commercial capacity totals 48,000L for now with an … how to set primary number on iphone 13http://www.hanbio.bioon.com.cn/ how to set primary number on iphone 12WebbHyaMab, based in the Pharmaceutical Valley of Zhangjiang Innovation Cluster, is committed to novel anti-cancer therapeutics including monoclonal antibodies (mAbs), … how to set primary key lengthWebb18 feb. 2024 · HY-0102 in Solid Tumor Drug Details: HY-0102 is under development for the treatment of locally advanced and metastatic solid tumors including head and neck cancer, liver cancer, colorectal cancer, lung cancer. The therapeutic candidate is administered through intravenous route. Report Coverage noted windows版本WebbAssignee: Shanghai Hyamab Biotech Co ., Ltd . IPC: C07K16/28. Abstract: Provided are an antibody targeting NKG2A, a preparation method therefor and use thereof. Specifically, … how to set primary microphoneWebb2 sep. 2024 · The latest news, comment and analysis about Shanghai HyaMab Biotechnology from the Vantage editorial team. how to set primary key using alter command